| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |